Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-70,063
Closed -$3.51M 33
2025
Q4
$3.51M Hold
70,063
2.27% 19
2025
Q3
$3.44M Sell
70,063
-6,190
-8% -$317K 2.38% 16
2025
Q2
$3.95M Hold
76,253
2.79% 14
2025
Q1
$3.56M Hold
76,253
2.52% 16
2024
Q4
$3.91M Hold
76,253
2.46% 15
2024
Q3
$3.39M Hold
76,253
2.22% 20
2024
Q2
$3.06M Sell
76,253
-19,065
-20% -$723K 2.57% 17
2024
Q1
$3.82M Hold
95,318
2.99% 15
2023
Q4
$3.59M Hold
95,318
2.65% 17
2023
Q3
$2.65M Hold
95,318
2.43% 17
2023
Q2
$2.88M Hold
95,318
2.82% 15
2023
Q1
$2.94M Sell
95,318
-19,335
-17% -$736K 2.46% 18
2022
Q4
$4.31M Sell
114,653
-160
-0.1% -$6.35K 3.15% 12
2022
Q3
$4.31M Buy
114,813
+27,500
+31% +$1.09M 3.2% 12
2022
Q2
$3.15M Hold
87,313
2.75% 17
2022
Q1
$4.28M Hold
87,313
3.31% 13
2021
Q4
$4.18M Buy
+87,313
New +$4.13M 3% 15

Other funds holding SNV

Petiole USA's SNV Position: Q1 2026 in Review

Petiole USA sold out of Synovus (SNV) in Q1 2026, closing a stake of 70,063 shares — an estimated $3.51M sold.

Petiole USA first reported a position in SNV in Q4 2021 and held it in 17 quarters. The position peaked at $4.31M in Q3 2022. 1 fund tracked by Wall St. Rank holds SNV as of Q1 2026.

  • Petiole USA reported no remaining Synovus position as of Q1 2026 after selling out during the quarter.
  • Petiole USA sold 70,063 Synovus shares in Q1 2026, an estimated $3.51M.
  • Petiole USA first reported a position in Synovus in Q4 2021 and held it in 17 quarters.
  • Petiole USA's Synovus position peaked at $4.31M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Synovus as of Q1 2026.

Based on Petiole USA's 13F filing for Q1 2026, filed 14 May 2026.